Uptiv Health Secures Strategic Funding to Expand Hybrid Infusion Care Nationwide
Uptiv Health, a Nashville-based health technology company redefining infusion care for patients with chronic conditions, has strengthened its early funding base and attracted strategic investment as it accelerates market expansion and enhances its hybrid care model. Founded in 2022, Uptiv combines in-clinic infusion services with virtual care capabilities to improve patient experience, streamline care delivery, and expand access to whole-person support across chronic disease populations.
In August 2023, Uptiv Health announced a $7.5 million seed funding round, marking its first significant venture financing and providing essential capital to launch its hybrid care model and open its initial infusion centers in Michigan. This seed round included backing from Redesign Health, a healthcare venture development platform that builds, funds, and scales companies addressing systemic challenges in care delivery and patient outcomes. The funding enabled Uptiv to expand services beyond traditional infusion settings by integrating digital tools, personalized care navigation, and a patient-centric mobile app to coordinate appointments, communication, and symptom tracking.
Since the seed raise, Uptiv Health has drawn additional investor interest, culminating in a strategic investment from The 81 Collection announced in December 2025. This partnership is intended to accelerate Uptiv’s national expansion strategy and support the next generation of its digital platform, which combines clinical excellence with technology-enabled care coordination and workflow efficiencies.
Uptiv’s hybrid model merges comfortable, personalized infusion suites with whole-person care services, including mental wellness support, care coordination, and chronic disease management. The 81 Collection’s investment reflects confidence in Uptiv’s ability to scale its differentiated approach nationally while maintaining high patient satisfaction and operational performance.
Backing from Redesign Health at the seed stage provided both capital and ecosystem support, embedding Uptiv within a portfolio of healthcare ventures that aim to modernize care delivery across multiple clinical domains. Redesign Health’s model pairs venture funding with operational expertise, enabling Uptiv to launch quickly and refine its go-to-market strategy in collaboration with clinical partners and technology stakeholders.
With the strategic investment from The 81 Collection, Uptiv has signaled its intent to build on early traction—serving thousands of patients with chronic conditions such as multiple sclerosis, Crohn’s disease, ulcerative colitis, and rheumatoid arthritis—while enhancing backend automation and digital care coordination. The funding is expected to support the opening of additional infusion centers, development of AI-enabled administrative workflows, and continued refinement of the Uptiv360 care experience that integrates behavioral health and chronic care management with core infusion therapy.
Uptiv’s value proposition lies in its patient-centric experience, which combines clinical infusion therapy in retail-based locations with a digital platform that simplifies onboarding, scheduling, payment, and communication with care teams. By reducing barriers to care and integrating services under a unified hybrid model, Uptiv aims to improve outcomes and satisfaction while lowering costs traditionally associated with hospital-based infusion therapies.
The company’s early funding and strategic investment arrive amid growing demand for innovations that address the complexity of chronic disease management and the inefficiencies of existing infusion care pathways. Uptiv’s leadership team, led by CEO and co-founder Torben Nielsen, has emphasized that both foundational capital and strategic partnerships are critical as the company scales its operations and deepens its value to patients, providers, and healthcare partners.
Total disclosed funding for Uptiv centers around the $7.5 million seed financing and the strategic capital deployed by The 81 Collection, positioning the company for continued growth in the competitive infusion and chronic care management landscape. As the company evolves its care model and expands geographically, its funding history reflects strong confidence from both venture builders and growth-oriented equity investors in Uptiv Health’s approach to transforming infusion care delivery.
